INTERCEPT PHARMACEUTICALS IN's ticker is and the CUSIP is 45845PAB4. A total of 9 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $20,712,300 | +22.6% | 21,000,000 | 0.0% | 0.01% | +37.5% |
| Q2 2023 | $16,888,196 | -2.7% | 21,000,000 | 0.0% | 0.01% | -11.1% |
| Q1 2023 | $17,363,331 | +10.2% | 21,000,000 | 0.0% | 0.01% | +12.5% |
| Q4 2022 | $15,760,500 | -0.6% | 21,000,000 | 0.0% | 0.01% | -11.1% |
| Q3 2022 | $15,863,000 | +14.2% | 21,000,000 | 0.0% | 0.01% | +28.6% |
| Q2 2022 | $13,885,000 | +8.1% | 21,000,000 | 0.0% | 0.01% | +40.0% |
| Q1 2022 | $12,846,000 | 0.0% | 21,000,000 | 0.0% | 0.01% | 0.0% |
| Q4 2021 | $12,846,000 | +0.9% | 21,000,000 | 0.0% | 0.01% | 0.0% |
| Q3 2021 | $12,730,000 | -9.6% | 21,000,000 | 0.0% | 0.01% | 0.0% |
| Q2 2021 | $14,083,000 | -37.7% | 21,000,000 | -39.1% | 0.01% | -44.4% |
| Q1 2021 | $22,622,000 | +9.2% | 34,500,000 | 0.0% | 0.01% | 0.0% |
| Q4 2020 | $20,713,000 | -13.9% | 34,500,000 | 0.0% | 0.01% | -25.0% |
| Q3 2020 | $24,060,000 | -6.2% | 34,500,000 | 0.0% | 0.01% | -7.7% |
| Q2 2020 | $25,648,000 | -14.1% | 34,500,000 | 0.0% | 0.01% | -35.0% |
| Q1 2020 | $29,870,000 | -35.1% | 34,500,000 | 0.0% | 0.02% | -16.7% |
| Q4 2019 | $45,992,000 | +43.4% | 34,500,000 | -2.8% | 0.02% | +41.2% |
| Q3 2019 | $32,083,000 | +4.1% | 35,500,000 | +14.5% | 0.02% | +6.2% |
| Q2 2019 | $30,830,000 | – | 31,000,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PenderFund Capital Management Ltd. | 11,795,000 | $13,303 | 4.18% |
| Context Capital Management, LLC | 20,230 | $16,727 | 1.40% |
| OAKTREE CAPITAL MANAGEMENT LP | 8,816,000 | $7,289,292 | 0.08% |
| GABELLI & Co INVESTMENT ADVISERS, INC. | 225,000 | $187,043 | 0.04% |
| Calamos Advisors LLC | 5,000,000 | $4,156,550 | 0.02% |
| FRANKLIN RESOURCES INC | 21,000,000 | $17,363,331 | 0.01% |
| Russell Investments Group, Ltd. | 1,785,000 | $1,497,379 | 0.00% |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 3,000,000 | $2,481,591 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |